BioCentury | Jul 17, 2017
Company News

Management tracks

...NASDAQ:MIRN). Cancer company Verastem Inc. (NASDAQ:VSTM) named Julie Feder CFO. She was CFO at the Clinton Health Access Initiative Inc....
BioCentury | Apr 25, 2016
Company News

Bristol-Myers, CHAI sales and marketing update

...and Daklinza is selective HCV NS5A protein inhibitor. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Clinton Health Access Initiative Inc....
BioCentury | Jun 15, 2015
Company News

J&J infectious news

...between the Medicines Patent Pool (Geneva, Switzerland), Drugs for Neglected Diseases initiative (DNDi) (Geneva, Switzerland), Clinton Health Access Initiative Inc....
Items per page:
1 - 3 of 3
BioCentury | Jul 17, 2017
Company News

Management tracks

...NASDAQ:MIRN). Cancer company Verastem Inc. (NASDAQ:VSTM) named Julie Feder CFO. She was CFO at the Clinton Health Access Initiative Inc....
BioCentury | Apr 25, 2016
Company News

Bristol-Myers, CHAI sales and marketing update

...and Daklinza is selective HCV NS5A protein inhibitor. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Clinton Health Access Initiative Inc....
BioCentury | Jun 15, 2015
Company News

J&J infectious news

...between the Medicines Patent Pool (Geneva, Switzerland), Drugs for Neglected Diseases initiative (DNDi) (Geneva, Switzerland), Clinton Health Access Initiative Inc....
Items per page:
1 - 3 of 3